154 related articles for article (PubMed ID: 32266559)
1. Salivary microRNAs identified by small RNA sequencing as potential predictors of response to intensity-modulated radiotherapy in head and neck cancer patients.
Ahmad P; Slavik M; Trachtova K; Gablo NA; Kazda T; Gurin D; Smilek P; Horakova Z; Gal B; Hermanova M; Slampa P; Sana J; Slaby O
Cell Oncol (Dordr); 2020 Jun; 43(3):505-511. PubMed ID: 32266559
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy.
Ahmad P; Sana J; Slavik M; Gurin D; Radova L; Gablo NA; Kazda T; Smilek P; Horakova Z; Gal B; Hermanova M; Slampa P; Slaby O
Cancer Genomics Proteomics; 2019; 16(2):139-146. PubMed ID: 30850365
[TBL] [Abstract][Full Text] [Related]
3. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
4. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
[TBL] [Abstract][Full Text] [Related]
5. Salivary MicroRNAs for Early Detection of Head and Neck Squamous Cell Carcinoma: A Case-Control Study in the High Altitude Mestizo Ecuadorian Population.
Salazar-Ruales C; Arguello JV; López-Cortés A; Cabrera-Andrade A; García-Cárdenas JM; Guevara-Ramírez P; Peralta P; Leone PE; Paz-Y-Miño C
Biomed Res Int; 2018; 2018():9792730. PubMed ID: 30584540
[TBL] [Abstract][Full Text] [Related]
6. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients.
Summerer I; Niyazi M; Unger K; Pitea A; Zangen V; Hess J; Atkinson MJ; Belka C; Moertl S; Zitzelsberger H
Radiat Oncol; 2013 Dec; 8():296. PubMed ID: 24373621
[TBL] [Abstract][Full Text] [Related]
7. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
8. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
[TBL] [Abstract][Full Text] [Related]
9. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients.
Summerer I; Unger K; Braselmann H; Schuettrumpf L; Maihoefer C; Baumeister P; Kirchner T; Niyazi M; Sage E; Specht HM; Multhoff G; Moertl S; Belka C; Zitzelsberger H
Br J Cancer; 2015 Jun; 113(1):76-82. PubMed ID: 26057452
[TBL] [Abstract][Full Text] [Related]
11. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
12. High-throughput sequencing of small RNA transcriptomes reveals critical biological features targeted by microRNAs in cell models used for squamous cell cancer research.
Severino P; Oliveira LS; Torres N; Andreghetto FM; Klingbeil Mde F; Moyses R; Wünsch-Filho V; Nunes FD; Mathor MB; Paschoal AR; Durham AM
BMC Genomics; 2013 Oct; 14():735. PubMed ID: 24160351
[TBL] [Abstract][Full Text] [Related]
13. Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study.
Duz MB; Karatas OF; Guzel E; Turgut NF; Yilmaz M; Creighton CJ; Ozen M
Cell Oncol (Dordr); 2016 Apr; 39(2):187-93. PubMed ID: 26650483
[TBL] [Abstract][Full Text] [Related]
14. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
16. Salivary miR-93 and miR-200a as post-radiotherapy biomarkers in head and neck squamous cell carcinoma.
Greither T; Vorwerk F; Kappler M; Bache M; Taubert H; Kuhnt T; Hey J; Eckert AW
Oncol Rep; 2017 Aug; 38(2):1268-1275. PubMed ID: 28677748
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.
Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J
Cells; 2019 Apr; 8(4):. PubMed ID: 31010087
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive study of smoking-specific microRNA alterations in head and neck squamous cell carcinoma.
Krishnan AR; Zheng H; Kwok JG; Qu Y; Zou AE; Korrapati A; Li PX; Califano JA; Hovell MF; Wang-Rodriguez J; Ongkeko WM
Oral Oncol; 2017 Sep; 72():56-64. PubMed ID: 28797462
[TBL] [Abstract][Full Text] [Related]
19. MiR-200b and miR-155 as predictive biomarkers for the efficacy of chemoradiation in locally advanced head and neck squamous cell carcinoma.
Hess AK; Müer A; Mairinger FD; Weichert W; Stenzinger A; Hummel M; Budach V; Tinhofer I
Eur J Cancer; 2017 May; 77():3-12. PubMed ID: 28347920
[TBL] [Abstract][Full Text] [Related]
20. An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.
Citron F; Armenia J; Franchin G; Polesel J; Talamini R; D'Andrea S; Sulfaro S; Croce CM; Klement W; Otasek D; Pastrello C; Tokar T; Jurisica I; French D; Bomben R; Vaccher E; Serraino D; Belletti B; Vecchione A; Barzan L; Baldassarre G
Clin Cancer Res; 2017 Jul; 23(14):3769-3780. PubMed ID: 28174235
[No Abstract] [Full Text] [Related]
[Next] [New Search]